TFDA-2024-0011-V111
Major variation for application TFDA-2024-0011. Major variation: Manufacturing Process Change for Lorlatenilib — routine update
Variation Number
TFDA-2024-0011-V111
Type
Major
Application
Change
Status
Blocked
Fee
€46,360
Submitted
2023-10-14
Approved
—
Description
Major variation: Manufacturing Process Change for Lorlatenilib — routine update